Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy E., Female, Under 40

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had been told she was all-clear/cancer-free after chemotherapy, had undergone double mastectomy with staged reconstruction planning, and was continuing close oncology reviews every 3-4 months.

The Patient StoryRead more →

Invasive Lobular Carcinoma: Jo's Survivor Story

Patient Info: Jo, Female, 50s

Jo recovered well from bilateral mastectomy and reconstruction. She remained on monthly Zoladex and daily anastrozole, with no chemotherapy or radiation required.

Lobular Breast Cancer AllianceRead more →

Stage III Breast Cancer: Katie's Survivor Story

Patient Info: Katie, Female, Under 40 | Stage III

Biomarkers: Hormone-sensitive breast cancer; specific receptor results not otherwise reported

As of December 2021, Katie had no evidence of cancer at the 5-year treatment mark after Stage III hormone-sensitive breast cancer treatment and later had twins after ovarian function returned.

Cleveland ClinicRead more →

Breast cancer with sarcoidosis that mimicked metastatic disease

Patient Info: Anonymized, Female, 40s

Biomarkers: ER-positive; PR-positive; HER2-negative.

Her most recent mammogram showed no recurrent breast cancer while she continued letrozole, goserelin, and six-monthly follow-up.

PubMed CentralRead more →

Breast Cancer: Brittney's Survivor Story

Patient Info: Brittney Rinella, Female, Under 40

As of August 2019, Brittney was cancer-free 4 years after breast cancer treatment with double mastectomy and 4 chemotherapy rounds plus goserelin injections to help preserve ovarian function; she later gave birth to her son.

Cleveland ClinicRead more →

Breast Cancer: Heather's Survivor Story

Patient Info: Heather Kokinda, Female, Under 40

As of March 2018, Heather had completed chemotherapy and double mastectomy, had a clear scan before trying to conceive again, and had given birth to another daughter in July 2017.

Cleveland ClinicRead more →

Localized hormone receptor-positive breast cancer disease-free 5 years after endocrine therapy switch

Patient Info: Anonymized, Female, 40s

Biomarkers: ER-positive; PR-positive; HER2-negative; low Ki-67; Oncotype DX 12

After lumpectomy and 36 months of adjuvant hormonal treatment, she remained disease-free at her last examination in March 2013, 5 years after diagnosis.

PubMed CentralRead more →